Weed (BUDZ) Return on Capital Employed (2011 - 2026)
Weed (BUDZ) recorded quarterly Return on Capital Employed of 202.11% in Q1 2026, down 3.04% quarter-over-quarter from 196.15% in Q4 2025, and down 50436.0% on a YoY basis from N/an in Q1 2025.
Weed (BUDZ) Return on Capital Employed (2011 - 2026) Analysis & Trends
Weed's Return on Capital Employed history runs 11 years deep, the most recent figure standing at 202.11% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 50436.0% year-over-year to 202.11%; the TTM figure through Mar 2026 stood at 202.11% (down 50436.0% YoY), while the FY2025 annual figure was 229.03%, down 61264.0% from the prior year.
- Return on Capital Employed was 202.11% for Q1 2026 at Weed, down from 196.15% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 980.82% in Q2 2023 to a low of 967.6% in Q1 2023.
- Historically, Return on Capital Employed has averaged 49.43% across 5 years, with a median of 136.02% in 2023.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed soared 117687 bps in 2023, then plunged 60498 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 262.12% in 2022, then jumped by 116 bps to 42.95% in 2023, then soared by 325 bps to 182.52% in 2024, then sank by 207 bps to 196.15% in 2025, then decreased by 3 bps to 202.11% in 2026.
- The last three Return on Capital Employed figures came in at 202.11% (Q1 2026), 196.15% (Q4 2025), and 141.58% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Weed | - | - | - | -202.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202.11% |
| Dec 31, 2025 | -196.15% |
| Sep 30, 2025 | 141.58% |
| Jun 30, 2025 | 172.23% |
| Mar 31, 2025 | 302.25% |
| Dec 31, 2024 | 182.52% |
| Sep 30, 2024 | -427.48% |
| Jun 30, 2024 | 375.84% |
| Mar 31, 2024 | 99.19% |
| Dec 31, 2023 | 42.95% |
| Sep 30, 2023 | -136.02% |
| Jun 30, 2023 | 980.82% |
| Mar 31, 2023 | -967.60% |
| Dec 31, 2022 | -262.12% |
| Sep 30, 2022 | -144.42% |
| Jun 30, 2022 | -196.05% |
| Mar 31, 2022 | -605.82% |
| Dec 31, 2021 | -514.20% |
| Sep 30, 2021 | -311.30% |
| Jun 30, 2021 | -292.12% |